Histone modification enzymes: novel targets for cancer drugs

Author： Kristeleit Rebecca Stimson Lindsay Workman Paul Aherne Wynne

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.9, Iss.1, 2004-05, pp. : 135-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Targets for Drugs in Schizophrenia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Deubiquitinating Enzymes as Therapeutic Targets in Cancer

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4039-4052

Bentham Science Publishers

Access to resources Recommend Favorite

Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology

By Shashni Babita Sakharkar Kishore R. Nagasaki Yukio Sakharkar Meena K.

Journal of Drug Targeting, Vol. 21, Iss. 2, 2013-02 ,pp. : 161-174

Informa Healthcare

Access to resources Recommend Favorite

Histone Modifications as Molecular Targets in Nasopharyngeal Cancer

Current Medicinal Chemistry, Vol. 23, Iss. 2, 2016-01 ,pp. : 186-197

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite